OrphAI Therapeutics
Manufacturing · Connecticut, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
530 Old Whitfield St, Guilford, Connecti...Website
www.orphai-therapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About OrphAI Therapeutics
At OrphAI Therapeutics, the company is focused on identifying and developing therapeutics for rare orphan conditions. The company accelerate the development process by using a variety of methods to identify and acquire promising pipeline assets - including data mining, deep learning, and in-licensing. The company's current clinical stage drug candidates target several orphan disorders including pulmonary sarcoidosis, bronchiolitis obliterans post lung transplant and amyotrophic lateral sclerosis.Explore more
OrphAI Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OrphAI Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once OrphAI Therapeutics has new funding data
Click to see if OrphAI Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at OrphAI Therapeutics
Earning: See what the market has to say on OrphAI Therapeutics recently announced quarterly report
Check out if OrphAI Therapeutics is spiking on competitors!
Product Launch: Get notified when OrphAI Therapeutics launches new products
OrphAI Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if OrphAI Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to OrphAI Therapeutics
Compare insights from companies similar to OrphAI Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
OrphAI Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
OrphAI Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about OrphAI Therapeutics.
OrphAI Therapeutics Tech Stack
A closer look at the technologies used by OrphAI Therapeutics
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Executive Move
Executive Moves, Board of Directors
Open Position
Open Position
OrphAI Therapeutics News & Media
Orphai Therapeutics’ Phase 2a LAM-001 Study Selected for Oral Presentation at the American Thoracic Society (ATS) 2026 International Conference
NEW HAVEN, Conn., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Orphai Therapeutics Inc. (“Orphai”), a clinical-stage biopharmaceutical company dedicated to advancing novel therapeutics for patients with diseases of significant unmet need, today announced that results from its Phase 2a study of LAM-001 in pulmonary hypertension have been slated for oral presentation at the American Thoracic Society (ATS) 2026 International Conference taking place May 15 – 20, 2026 in Orlando, FL.OrphAI Therapeutics Announces Appointment of Dr. Aaron Waxman to Board of Directors
Leading clinician and researcher in Pulmonary Disease Therapeutics Leading clinician and researcher in Pulmonary Disease TherapeuticsOrphAI Therapeutics Appoints Jay Fine to Board
GUILFORD, Conn., Jan. 24, 2024 (GLOBE NEWSWIRE) — OrphAI Therapeutics Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced... Read More The post OrphAI Therapeutics Appoints Jay Fine to Board appeared first on citybiz.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OrphAI Therapeutics
Sign Up For FreeTo access detailed company insights
At OrphAI Therapeutics, the company is focused on identifying and developing therapeutics for rare orphan conditions. The company accelerate the development process by using a variety of methods to identify and acquire promising pipeline assets - including data mining, deep learning, and in-licensing. The company's current clinical stage drug candi... Read More
